New-Onset Catatonia and Delirium in a COVID-Positive Patient
暂无分享,去创建一个
[1] A. Heidari,et al. Postinfectious COVID-19 Catatonia: A Report of Two Cases , 2021, Frontiers in Psychiatry.
[2] Margaret E. Wohlleber,et al. COVID-19 and Catatonia: A Case Series and Systematic Review of Existing Literature , 2021, Journal of the Academy of Consultation-Liaison Psychiatry.
[3] S. Kumar,et al. Neuropsychiatric and Cognitive Sequelae of COVID-19 , 2021, Frontiers in Psychology.
[4] Ankit Jain,et al. Posttraumatic Stress Disorder Exacerbation as a Result of Public Masking in Times of COVID-19. , 2020, The primary care companion for CNS disorders.
[5] A. Ruiz,et al. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia , 2020, Frontiers in Aging Neuroscience.
[6] R. Baweja,et al. Mental Health Crisis Secondary to COVID-19-Related Stress: A Case Series From a Child and Adolescent Inpatient Unit. , 2020, The primary care companion for CNS disorders.
[7] David A. Ross,et al. COVID-19 Catatonia—Would We Even Know? , 2020, Biological Psychiatry.
[8] F. Motiwala,et al. Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician , 2020, Journal of arrhythmia.
[9] Z. Mansuri,et al. Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective. , 2020, The primary care companion for CNS disorders.
[10] M. K. Zafar,et al. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. , 2020, The primary care companion for CNS disorders.
[11] Christopher T. Lim,et al. A Case of Catatonia in a Man With COVID-19 , 2020, Psychosomatics.
[12] Paolo Fusar-Poli,et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic , 2020, The Lancet Psychiatry.
[13] A. Francis,et al. Catatonia revived: a unique syndrome updated , 2020, International review of psychiatry.
[14] G. Northoff,et al. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[15] G. Ungvari,et al. The pharmacological treatment of catatonia: an overview , 2011, European Archives of Psychiatry and Clinical Neuroscience.